Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 16th, 2022 • Cue Biopharma, Inc. • Pharmaceutical preparations
AMENDMENT NO. 1 TO CONSULTING AGREEMENTConsulting Agreement • March 16th, 2022 • Cue Biopharma, Inc. • Pharmaceutical preparations • Massachusetts
THIS AMENDMENT NO. 1 TO CONSULTING AGREEMENT (this “Amendment”), dated as of December 15, 2021, is entered into by and between Cue Biopharma, Inc., a Delaware corporation (the “Company”), and Kenneth J. Pienta (the “Consultant”). Reference is made to that certain Consulting Agreement, dated as of January 1, 2017, by and between the Company and the Consultant (the “Agreement”).
